Although numerous states have granted authorization for health-related cannabis usage, it stays categorized being a Program one drug below federal expectations, lacking identified healthcare programs and posing an important risk of abuse. Additionally, According to the American Modern society of Scientific Oncology's 2017 recommendations, there